Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Biden's Executive Order to Advance Biotechnology, Biomanufacturing Prioritizes Science to Solve Global Challenges
September 12, 2022
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization, released the following statement in response to the Biden Administration’s “Advancing Biotechnology and Biomanufacturing” Executive Order: “BIO welcomes…
BIO Calls for Actions to Bolster IRA's Climate Investments by Advancing Biotech
September 8, 2022
As the Biden Administration begins implementation of the Inflation Reduction Act, the Biotechnology Innovation Organization today called on the administration to take additional steps to foster the development and deployment of pioneering…
With Plans to Build World-Class Event in 2023, BIO Cancels 2022 Impact Ag & Environment Conference
August 15, 2022
The Impact Ag & Environment Conference hosted by the Biotechnology Innovation Organization has been canceled for 2022. BIO is shifting its focus to planning a must-attend conference in Raleigh, N.C., in September 2023.BIO had planned to host the…
Final reconciliation package a "disservice to patients and researchers"
August 7, 2022
Senate lawmakers today passed a sweeping, $740 billion reconciliation package after an all-night session. Following the vote, Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the following…
Price Controls in Reconciliation Package A "Disservice to Millions of American Patients"
August 5, 2022
As Senate lawmakers look to finalize a budget reconciliation package this weekend, Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement related to price controls…
Nebraska Governor Pete Ricketts to Headline BIO’s Impact Ag & Environment Conference in Omaha
July 21, 2022
BIO is hosting the Impact Ag & Environment Conference, in-person for the first time in three years, in Omaha, Neb., Sept. 19-21, 2022. Headlined by Nebraska Gov. Pete Ricketts, the event will convene leaders across the bioeconomy whose…
Berlin Declaration will "save lives" in the future
July 20, 2022
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week released the “Berlin Declaration” — a framework to work with G7 and G20 on a joint solution for better access to vaccines and treatments…
Recently Passed House Appropriations Bill Will Spur Agricultural Innovation
July 20, 2022
Washington, D.C. (July 20, 2022) – John Murphy, chief policy officer for the Biotechnology Innovation Organization, released the following statement in response to the U.S. House of Representatives’ passing the fiscal 2023 Agriculture, Rural…
New drug pricing deal could propel us "light years back into the dark ages of biomedical research"
July 6, 2022
Democratic lawmakers in the U.S. Senate advanced drug pricing legislation today that would drastically alter the Medicare program. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released…
WTO Decision on Waiving Intellectual Property Rights is a Distraction from the Real Work that Needs to be Done
June 17, 2022
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to a decision by the World Trade Organization (WTO) Ministerial Conference (MC12) to endorse a COVID-19…